GPA33 and colitis: The ease with which Gpa33−/− mice can be manipulated to elicit a suite of intestinal pathologies, including loss of oral tolerance, severe colitis and CAC, suggests that this model might provide an attractive option for preclinical studies aimed at identifying drugs capable of restoring intestinal barrier function.